Epidemiologic case investigation on the zoonotic transmission of Methicillin-resistant Staphylococcus pseudintermedius among dogs and their owners

Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE LONDON
Autores
GUIMARAES, Luciana
TEIXEIRA, Izabel Mello
SILVA, Isabella Thomaz da
ANTUNES, Milena
PESSET, Camilla
FONSECA, Carolina
SANTOS, Ana Luiza
PENNA, Bruno
Citação
JOURNAL OF INFECTION AND PUBLIC HEALTH, v.16, suppl.1, p.183-189, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Dogs often carry methicillin-resistant Staphylococci asymptomatically. These bacteria are frequently linked to conditions such as canine pyoderma and otitis. Close interaction between dogs and humans can facilitate the exchange of resistant strains, particularly Methicillin-resistant Staphylococcus pseudintermedius (MRSP). This represents a public health issue, since these strains, in addition to occasionally causing infections in humans, can also serve as a source of resistance and virulence genes for strains of greater importance in human medicine, such as Staphylococcus aureus. Furthermore, MRSP strains are often multidrug resistant, which ends up compromising the treatment of infections. This study aimed to assess the potential transmission of Staphylococcus pseudintermedius among dogs and their owners. We examined a total of one hundred canine samples collected from cases of pyoderma and otitis to detect the presence of staphylococci. Simultaneously, we conducted evaluations on all dog owners. Staphylococci strains were identified using MALDI-TOF MS and PCR targeting the nuc gene. Methicillin resistance screening was also performed by detecting the mecA gene using PCR. Among the sampled dogs, 64 carried S. pseudintermedius. Nine were identified as MRSP. In six instances, dogs and their owners exhibited S. pseudintermedius. These samples underwent genome sequencing and were screened for antimicrobial resistance genes, SCCmec typing, MLST characterization, and Single Nucleotide Polymorphisms (SNP) analyses. The results of the phylogenetic analysis revealed that in three cases, dogs and owners had closely related isolates, suggesting interspecies transmission. Two of these cases involved MRSP and one MSSP. Moreover, in the two MRSP cases, the same SCCmec type (type V) was detected. Additionally, the sequence type was consistent across all three cases involving dogs and owners (MSSP ST2277, MRSP ST2282, and ST2286). These findings strongly indicate a transmission event. Since Staphylococcus pseudintermedius is primarily isolated from canine samples, it is plausible that dogs may have acted as a potential source. In the remaining three cases, despite identifying the same species in both samples, they had notable phylogenetic differences. (c) 2023 The Author(s).
Palavras-chave
Staphylococcus pseudintermedius, MRSP, Zoonotic transmission
Referências
  1. Bannoehr J, 2012, VET DERMATOL, V23, P253, DOI 10.1111/j.1365-3164.2012.01046.x
  2. Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088
  3. Bhooshan S, 2020, GMS HYG INFECT CONTR, V15, DOI 10.3205/dgkh000367
  4. Börjesson S, 2015, EUR J CLIN MICROBIOL, V34, P839, DOI 10.1007/s10096-014-2300-y
  5. Carroll KC, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009961
  6. Chaoui L, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/3236526
  7. Chuang CY, 2010, J CLIN MICROBIOL, V48, P1497, DOI 10.1128/JCM.02033-09
  8. Cuny C, 2022, MICROORGANISMS, V10, DOI 10.3390/microorganisms10040677
  9. Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147
  10. Diaz MA, 2019, BMJ CASE REP, V12, DOI 10.1136/bcr-2019-231489
  11. Duim B, 2016, J CLIN MICROBIOL, V54, P283, DOI 10.1128/JCM.01288-15
  12. Fungwithaya P, 2022, VET WORLD, V15, P1087, DOI 10.14202/vetworld.2022.1087-1096
  13. Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543
  14. Garbacz K, 2013, CURR MICROBIOL, V66, P169, DOI 10.1007/s00284-012-0254-9
  15. Gortel K, 1999, AM J VET RES, V60, P1526
  16. Grönthal T, 2017, J ANTIMICROB CHEMOTH, V72, P1021, DOI 10.1093/jac/dkw559
  17. Han JI, 2016, VET J, V212, P15, DOI 10.1016/j.tvjl.2015.10.059
  18. Hanselman BA, 2009, CAN VET J, V50, P954
  19. Kmieciak W, 2018, FOLIA MICROBIOL, V63, P743, DOI 10.1007/s12223-018-0615-2
  20. Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130
  21. Letunic I, 2021, NUCLEIC ACIDS RES, V49, pW293, DOI 10.1093/nar/gkab301
  22. Lozano C, 2017, VECTOR-BORNE ZOONOT, V17, P268, DOI 10.1089/vbz.2016.2048
  23. Maali Y, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00221
  24. Malisová L, 2019, FOLIA MICROBIOL, V64, P231, DOI 10.1007/s12223-018-0647-7
  25. Menandro ML, 2019, COMP IMMUNOL MICROB, V66, DOI 10.1016/j.cimid.2019.101331
  26. Morris DO, 2017, VET DERMATOL, V28, P304, DOI 10.1111/vde.12444
  27. Moses IB, 2023, MICROORGANISMS, V11, DOI 10.3390/microorganisms11030581
  28. Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091
  29. Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x
  30. Peacock SJ, 2015, ANNU REV BIOCHEM, V84, P577, DOI 10.1146/annurev-biochem-060614-034516
  31. Penna B, 2022, BRAZ J MICROBIOL, V53, P2335, DOI 10.1007/s42770-022-00852-9
  32. Perkins AV, 2022, VET RECORD OPEN, V9, DOI 10.1002/vro2.41
  33. Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078
  34. Phumthanakorn N, 2017, J MICROBIOL METH, V142, P90, DOI 10.1016/j.mimet.2017.09.003
  35. Richards AC, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00631-18, 10.1128/iai.00631-18]
  36. Riegel P, 2011, INT J MED MICROBIOL, V301, P237, DOI 10.1016/j.ijmm.2010.09.001
  37. Rodrigues AC, 2018, MICROB DRUG RESIST, V24, P434, DOI 10.1089/mdr.2017.0063
  38. Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09
  39. Somayaji R, 2016, DIAGN MICR INFEC DIS, V85, P471, DOI 10.1016/j.diagmicrobio.2016.05.008
  40. Stegmann R, 2010, J ANTIMICROB CHEMOTH, V65, P2047, DOI 10.1093/jac/dkq241
  41. Viau R, 2015, Open Forum Infect Dis, P1, DOI [10.1093/o, DOI 10.1093/O]
  42. WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018
  43. Yarbrough ML, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01788-17, 10.1128/JCM.01788-17]
  44. Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005